Sort
85,873 grants matching “alzheimers”
Tools for Distance Delivery of an Evidence-based AD Family Caregiver Intervention
$902,320John V Hobday · Healthcare Interactive, Inc. · R44 · FY2014 · AG
Modulatory Role of Blood-Brain-Barrier and Enzymatic Activity in an Innovative Human Model of Cholinergic Drug Induced Dementia
$902,299James J Hickman · Hesperos, Llc · R44 · FY2022 · AG
Administrative Core
$902,222Thomas J. Grabowski · University Of Washington · P50 · FY2019 · AG
Administrative Data Transfer Masking, Access, and Ethics Core
$902,166Steven C Marcus · University Of Michigan At Ann Arbor · U54 · FY2025 · AG
Administrative Data Transfer Masking, Access, and Ethics Core
$902,135Steven C Marcus · University Of Michigan At Ann Arbor · U54 · FY2024 · AG
Pesticides, Olfaction, and Neurodegeneration Among US Farmers
$902,103Honglei Chen · Michigan State University · R01 · FY2019 · ES
Targeting REST in Alzheimer's Disease
$901,982Bruce A Yankner · Harvard Medical School · R01 · FY2024 · AG
Targeting REST in Alzheimer's Disease
$901,982Bruce A Yankner · Harvard Medical School · R01 · FY2023 · AG
China Health and Retirement Longitudinal study
$901,970Yaohui Zhao · Peking University · R01 · FY2022 · AG
Epidemiology of Age-related Dementia, Mild Cognitive Impairment and Brain Pathology in a Multiethnic Cohort of Oldest-Old
$901,957Rachel A Whitmer · Kaiser Foundation Research Institute · RF1 · FY2017 · AG
Core D: Genomics and Biomarker Core
$901,942Anthony John Griswold · University Of Miami School Of Medicine · U19 · FY2024 · AG
INDEPENDENT AND DEPENDENT LIFE IN THE ELDERLY
$901,845University Of Kentucky · R01 · FY2000 · AG
Project 2 - Influence of controlled diets on gut microbiome, metabolome and cognitive function
$901,752Rima F Kaddurah-Daouk · Duke University · U19 · FY2023 · AG
Aging in 1000 healthy midlife adults: Phase 52 of the Dunedin Study
$901,709Terrie Edith Moffitt · Duke University · R01 · FY2022 · AG
Developing a PRogram to Educate and Sensitize Caregivers to Reduce the Inappropriate Prescription Burden in Elderly with Alzheimer's Disease Study (D-PRESCRIBE-AD)
$901,588Jerry H Gurwitz · Univ Of Massachusetts Med Sch Worcester · R33 · FY2022 · AG
Advance Care Planning in the Dementias: Culturally-Tailored Caregiver Education for African Americans
$901,538William B Collinge · Collinge And Associates · R44 · FY2020 · AG
Uncovering the origin of hypermutability in adult brains
$901,382Alexej Abyzov · Mayo Clinic Rochester · R01 · FY2024 · MH
Targeting REST in Alzheimer's Disease
$901,345Bruce A Yankner · Harvard Medical School · R01 · FY2022 · AG
Neural and Biochemical Mechanisms of Cognitive Aging
$901,078William J. Jagust · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2025 · AG
A Comprehensive Platform to study drug interaction with physiologically important
$901,047Yong Huang · Optivia Biotechnology, Inc. · R44 · FY2014 · MH
A Comprehensive Platform to study drug interaction with physiologically important
$901,047Yong Huang · Optivia Biotechnology, Inc. · R44 · FY2013 · MH
Planning an Adaptive Clinical Trial of Cognitive Training to Improve Function and Delay Dementia
$901,042Jerri Edwards · University Of South Florida · U01 · FY2018 · AG
Pharmacokinetic/toxicology & in vivo efficacy of potential AD therapeutic agents
$900,969Arpita Das · Neuronautics, Inc. · R44 · FY2006 · AG
Digital Detection of Dementia Studies (D cubed Studies).
$900,884Malaz Boustani · Indiana University Indianapolis · R01 · FY2022 · AG
Neuroprotective Effects of Vascular Endothelial Growth Factor in Alzheimer's Disease
$900,827Timothy J Hohman · Vanderbilt University Medical Center · R01 · FY2019 · AG